Our People
Leadership Team
View on LinkedIn →
Hannah Zhang, M.S.F.
Chief Executive Officer
Leads Zepto’s strategy and mission, representing the company across clinical, regulatory, and investor partnerships.
View on LinkedIn →
Dong Chen, M.D., Ph.D.
Chief Medical Officer
Guides the clinical and medical strategy behind Zepto’s diagnostic platform and its use in patient care.
View on LinkedIn →
Wei Wang, Ph.D.
VP of Regulatory
Directs assay development and Zepto’s Contract Research Organization services for partner companies.
View on LinkedIn →
Minggan Li, Ph.D.
Senior Mechanical Engineer
Leads mechanical design and engineering for Zepto’s diagnostic hardware and cartridge systems.
View on LinkedIn →
Keping Song, M.S.E.
VP of Quality & Engineering
Oversees quality systems and engineering across Zepto’s diagnostic platform and manufacturing.
View on LinkedIn →
Xiaoying Liu, Ph.D.
VP of Assay Development
Leads the design and validation of Zepto’s molecular assays, including the FungiFlex® panel.
Medical & Technical Advisory Board
Infectious disease and molecular diagnostics experts guiding Zepto’s clinical and scientific direction.
View on Bio →

David S. Perlin, Ph.D.
Chief Scientific Officer, Hackensack Meridian Center for Discovery and Innovation
Biomedical scientist with 30+ years in infectious disease research and Editor-in-Chief of the Journal of Fungi.
View on Bio →

Sean Zhang, M.D., Ph.D.
Associate Professor & Laboratory Director, Mycology Laboratory, Johns Hopkins
Co-founding chair of the Fungal Diagnostics Laboratory Consortium and a leading voice in fungal diagnostics.
View on Bio →

Bruce Klein, M.D., Ph.D.
Professor & Division Chief of Infectious Diseases, University of Wisconsin
Leads research on Blastomyces dermatitidis and fungal immunology, with over two decades in pediatric infectious disease.
View on Bio →

Gang Zheng, M.D., Ph.D.
Professor, Department of Laboratory Medicine and Pathology, Mayo Clinic
Focuses on circulating cell-free DNA and NGS-based liquid biopsy for cancer diagnostics.
View on LinkedIn →

Ming Mai, M.S.
Senior Molecular Test Developer, Mayo Clinic
Molecular diagnostics and laboratory-developed test expert with 20+ years across LDT and FDA-cleared assays.
Partnerships
Working with industry leaders to deliver clinically actionable solutions

